Cargando…

BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions

The BRAF inhibitors vemurafenib, dabrafenib and encorafenib are used in the treatment of patients with BRAF-mutant melanoma. They selectively target BRAF kinase and thus interfere with the mitogen-activated protein kinase (MAPK) signalling pathway that regulates the proliferation and survival of mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proietti, Ilaria, Skroza, Nevena, Michelini, Simone, Mambrin, Alessandra, Balduzzi, Veronica, Bernardini, Nicoletta, Marchesiello, Anna, Tolino, Ersilia, Volpe, Salvatore, Maddalena, Patrizia, Di Fraia, Marco, Mangino, Giorgio, Romeo, Giovanna, Potenza, Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408709/ https://www.ncbi.nlm.nih.gov/pubmed/32645969 http://dx.doi.org/10.3390/cancers12071823

Ejemplares similares

Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
por: Proietti, Ilaria, et al.
Publicado: (2020)

Do Diet and Lifestyles Play a Role in the Pathogenesis of NMSCs?
por: Skroza, Nevena, et al.
Publicado: (2020)

Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis
por: Skroza, Nevena, et al.
Publicado: (2020)

IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art
por: Bernardini, Nicoletta, et al.
Publicado: (2019)

A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma
por: Potenza, Concetta, et al.
Publicado: (2018)

Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
por: Skroza, Nevena, et al.
Publicado: (2021)

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)

Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience
por: Skroza, Nevena, et al.
Publicado: (2021)

Aesthetic Treatments in Cancer Patients
por: Proietti, Ilaria, et al.
Publicado: (2021)

Eruptive Blue Nevi of the Scalp in a Patient with Mayer–Rokitansky–Küster–Hauser Syndrome during Isotretinoin Therapy
por: Skroza, Nevena, et al.
Publicado: (2019)

Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
por: Proietti, Ilaria, et al.
Publicado: (2023)

Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy
por: Proietti, Ilaria, et al.
Publicado: (2021)

How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy
por: Bernardini, N., et al.
Publicado: (2021)

A Case of Psoriatic Disease and Hidradenitis Suppurativa in a Child with Chromosome 17q21.31 Microduplication Syndrome
por: Tolino, Ersilia, et al.
Publicado: (2023)

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Adverse skin reactions to personal protective equipment during COVID‐19 pandemic in Italian health care workers
por: Proietti, Ilaria, et al.
Publicado: (2022)

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

The Role of the Western Diet on Atopic Dermatitis: Our Experience and Review of the Current Literature
por: Ilaria, Proietti, et al.
Publicado: (2023)

A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study
por: Potenza, Concetta, et al.
Publicado: (2016)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
por: Skroza, Nevena, et al.
Publicado: (2018)

Management of psoriatic patients in biologic treatment associated with infectious comorbidities
por: Nicoletta, Bernardini, et al.
Publicado: (2020)

Correlations between Psoriasis and Inflammatory Bowel Diseases
por: Skroza, Nevena, et al.
Publicado: (2013)

A rare BRAF V600E mutation detected by next‐generation sequencing in a superficial spreading melanoma: case report and potential diagnostic implications
por: Proietti, I., et al.
Publicado: (2020)

Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature
por: Proietti, Ilaria, et al.
Publicado: (2023)

A Case Report of Monkeypox in an Adult Patient from Italy: Clinical and Dermoscopic Manifestations, Diagnosis and Management
por: Proietti, Ilaria, et al.
Publicado: (2022)

BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
por: Chiappetta, Caterina, et al.
Publicado: (2015)

The Dermatological Effects and Occupational Impacts of Personal Protective Equipment on a Large Sample of Healthcare Workers During the COVID-19 Pandemic
por: Santoro, Paolo Emilio, et al.
Publicado: (2022)

Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa
por: Fania, Luca, et al.
Publicado: (2022)

Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond
por: Jung, Thomas, et al.
Publicado: (2021)

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
por: Rossi, Sabrina, et al.
Publicado: (2016)

Breg Cells in Celiac Disease Isolated or Associated to Hashimoto's Thyroiditis
por: Santaguida, Maria Giulia, et al.
Publicado: (2018)

Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
por: Lelliott, Emily J., et al.
Publicado: (2021)

A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial
por: Dall’Oglio, Federica, et al.
Publicado: (2021)

The Skin in Celiac Disease Patients: The Other Side of the Coin
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: A novel strategy for human BRAF-driven colorectal carcinoma
por: Condelli, Valentina, et al.
Publicado: (2015)

The Effect of Different Antibiotic Regimens on Bacterial Resistance: A Systematic Review
por: Patini, Romeo, et al.
Publicado: (2020)

Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
por: Focaccetti, Chiara, et al.
Publicado: (2019)

microRNA‐377‐3p downregulates the oncosuppressor T‐cadherin in colorectal adenocarcinoma cells
por: Di Palo, Armando, et al.
Publicado: (2021)

Italian health care workers and Adverse skin reactions to personal protective equipment during Covid-19 pandemic
por: Santoro, Paolo Emilio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0tvdsn2lf56fqe0f32jfuruphb